IntroductionMany people of all ages all over the world suffer from serious bone diseases such as bone fractures, bone tumors, and osteoporosis. The limited treatment options for these disorders indicate a need for new therapies. Cellular therapy is one of the promising methods in orthopedic clinical trials (Pytlik et al., 2009;Seong et al., 2010). To date, the most popular cells used in cellular therapies are mesenchymal stem cells (MSCs). They can be isolated from different adult tissues such as the bone marrow, placenta, liver, adipose, periosteum, and testes (Vater et al., 2011). Adipose tissue is one of the most preferred sources because it can be obtained by less invasive methods and in larger quantities than the other adult tissues (Liu et al., 2007). Adipose tissue-derived MSCs (ADMSCs) have a great plasticity for variable cell types. For the characterization of ADMSC plasticity, one of the most widely accepted methods is differentiating them into osteoblasts, chondrocytes, and adipocytes in vitro (Vater et al, 2011).Recently, several experiments have been performed to demonstrate the existence of adipose tissue-derived progenitors that give rise to bone (Liu et al., 2007;Arrigoni et al., 2009;Song et al., 2011;Çapkın, 2012). It was reported
Materials and methodsAll cell culture materials and differentiation reagents were purchased from Greiner Bio-One (Germany) and Sigma Chemical Co. (USA) respectively, unless otherwise noted. Alpha minimum essential medium (MEM) (HyClone, SH30007.04), Dulbecco's modified Eagle's medium (DMEM) (high glucose) (FG0435), fetal bovine serum (FBS) (S0115), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (L1613), gentamicin (A2710), phosphate buffered saline (PBS) (L1835), Hank's balanced salt solution Abstract: Mesenchymal stem cells (MSCs) can be found in many types of adult tissues such as the bone marrow, adipose, placenta, liver, and periosteum. Recently, adipose tissue-derived MSCs (ADMSCs) have become one the most preferred MSC types because of their fast proliferation rate, abundance, and high plasticity for variable cell types. It is known that ADMSCs are able to differentiate into various cells, including osteoblasts, so they are quite promising for orthopedic clinical trials. The present study aimed to compare the osteogenic differentiation conditions of MSCs from human adipose tissue (hADMSC) and those of MSCs from rat adipose tissue (rADMSC). Therefore, differentiation experiments with five different media and two (human and rat) ADMSC types were performed and the mineralization responses of hADMSCs and rADMSCs were different.